Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients–authors' response

M Sun, H Lai, Z Zhang, L Ge - Journal of Antimicrobial …, 2023 - academic.oup.com
We thank Drs Kow, Ramachandram and Hasan for their interest in our review and their
knowledgeable comments. 1 We agree with your thoughtful view that the most important …
被引用次数：1 相关文章

[引用][C] Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients-authors' response

M Sun, H Lai, Z Zhang, L Ge - The Journal of antimicrobial … - pubmed.ncbi.nlm.nih.gov
Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis
of 14 randomized trials with 34 570 patients-authors' response Molnupiravir for the …

[引用][C] Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients-authors' response.

M Sun, H Lai, Z Zhang, L Ge - The Journal of Antimicrobial …, 2023 - europepmc.org
Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis
of 14 randomized trials with 34 570 patients-authors' response. - Abstract - Europe PMC Sign in …